Lodoxamidetromethamine
|
|
|
- CAS-Nr.
- 63610-09-3
- Englisch Name:
- Lodoxamidetromethamine
- Synonyma:
- AloMide;AlMide;U-42585-E;LodoxaMide troMetaMol;Lodoxamidetromethamine;Lodoxamide Tromethamide;LodoxaMide troMethaMineon;Lodossammonium butanetriol;LodoxaMide troMethaMine salt;Lodoxamide tromethamine (U 42585 E)
- CBNumber:
- CB51074423
- Summenformel:
- C15H17ClN4O9
- Molgewicht:
- 432.77
- MOL-Datei:
- 63610-09-3.mol
|
Lodoxamidetromethamine Eigenschaften
- storage temp.
- under inert gas (nitrogen or Argon) at 2–8 °C
- L?slichkeit
- DMSO: 20 mg/mL (36.11 mM and warming)
- Aggregatzustand
- Solid
- Farbe
- White to light yellow
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
|
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
|
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
|
|
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
Lodoxamidetromethamine Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Lodoxamide tromethamine was launched as an ophthalmic formulation for the
treatment of allergic conjunctivitis. It appears to act as a mast cell stabilizer inhibiting
degranulation and the release of histamine and other vasoactive products in a similar
manner to sodium cromoglycate. The compound is also under investigation as an
orally active antiallergic/antiasthmatic agent.
Verwenden
cataract treatment
Allgemeine Beschreibung
Lodoxamidetromethamine, N, N -(2-chloro-5-cyano-m-phenylene)dioxamicacid (Alomide), is a white crystalline, water-solublepowder. The only significant structural similarity betweenlodoxamide and cromolyn and nedocromil is the presence oftwo acidic groups. Lodoxamide is indicated in the treatmentof the ocular disorders including vernal keratoconjunctivitis,vernal conjunctivitis, and vernal keratitis. Lodoxamide isavailable as a 0.1% solution, with each milliliter containing1.78 mg of lodoxamide tromethamine equivalent to 1 mg oflodoxamide. The solution contains the preservative benzalkoniumchloride (0.007%) as well as mannitol, hydroxypropylmethylcellulose, sodium citrate, citric acid, edetatedisodium, tyloxapol, hydrochloric acid and/or sodium hydroxide(to adjust pH), and purified water.
The dose for adults and children older than 2 years of ageis 1 to 2 drops in each affected eye 4 times daily for up to 3months. The most frequently reported ocular adverse experienceswere transient burning, stinging, or discomfort oninstillation.
Lodoxamidetromethamine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Lodoxamidetromethamine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 111)Lieferanten
63610-09-3()Verwandte Suche:
- Lodoxamidetromethamine
- LodoxaMide troMethaMineon
- AlMide
- LodoxaMide troMetaMol
- LodoxaMide troMethaMine salt
- U-42585-E
- Lodoxamide tromethamine (U 42585 E)
- 2-Amino-2-(hydroxymethyl)propane-1,3-diol hemi(2,2'-((2-chloro-5-cyano-1,3-phenylene)bis(azanediyl))bis(2-oxoacetate))
- Lodoxamide Tromethamide
- AloMide
- Lodoxamide tromethamine, 10 mM in DMSO
- Lodossammonium butanetriol
- 63610-09-3
- C11H6ClN3O62C4H11NO3
- C19H28ClN5O12
- API
